Share
News

3 Hospitalized with 'Unusual Symptoms' After Taking Newest COVID Vaccine

Share

Three Norwegian health care workers have been hospitalized after receiving the newly-unveiled single-dose AstraZeneca COVID-19 vaccine, authorities have announced, which has led to a temporary suspension of giving out the shot.

Reuters reported that the workers experienced issues relating to blood clots and other vascular issues. Norwegian authorities did not say how long the distribution of the vaccine would be halted as those people remain hospitalized.

Sigurd Hortemo with the Norwegian Medicines Agency told reporters at a media briefing with members of the Norwegian Institute of Public Health that each of the hospitalized health care workers were under the age of 50, but said the hospitalizations could not be definitively linked to the shot.

“We do not know if the cases are linked to the vaccine,” Hortemo said.

The hospitalizations will be investigated by the European Medicines Agency, Hortemo added.

Trending:
'Looks Like a Hostage Photo': Twitter Users Howl After Harris Staffer Stages Pic to Quiet Bad Press

Steinar Madsen, the medical director at the Norwegian Medicines Agency, told regional media that the affected individuals were very ill after receiving the shots.

“They have very unusual symptoms: bleeding, blood clots and a low count of blood platelets,” Madsen said. “They are quite sick … We take this very seriously.”

Reuters reported that no such issues were reported during its clinical trials.

AstraZeneca defended the vaccine while pointing out that those hospitalized might have experienced their symptoms with or without taking its single-shot vaccine.

Would you take the AstraZeneca single-dose COVID-19 vaccine?

“In fact, the reported numbers of these types of events for COVID-19 Vaccine AstraZeneca are not greater than the number that would have occurred naturally in the unvaccinated population,” the pharmaceutical giant said.

The European Medicines Agency maintained that the benefits of the shot still outweigh the risks.

Denmark had already stopped the company’s shots forgoing into arms, and health authorities in Iceland followed suit this past week. Austrian authorities had previously stopped using one batch of the vaccines over concerns with the shot, as had authorities in Italy.

Meanwhile, Thailand became the first Asian country to halt the use of the company’s vaccine this past week, CNBC reported. The country’s health officials were vague when announcing the suspension.

Thai Public Health Ministry secretary Kiattiphum Wongjit called the shot a “good vaccine,” but said it would be paused because the emergence of new cases is being slowed through mitigation efforts such as quarantines.

Related:
Vax Mandates for Holiday Travelers? Psaki Makes Chilling Admission on Possible Domestic Travel Restrictions

AstraZeneca developed the single-dose vaccine in a collaboration with the University of Oxford in the U.K.

Roughly five million Europeans had received the vaccine as of this past Wednesday.

Truth and Accuracy

Submit a Correction →



We are committed to truth and accuracy in all of our journalism. Read our editorial standards.

Tags:
, , , ,
Share
Johnathan "Kipp" Jones has worked as a reporter, an editor and a producer in radio, television and digital media. He is a proud husband and father.
Johnathan "Kipp" Jones has worked as an editor and producer in radio and television. He is a proud husband and father.




Conversation

The Western Journal is pleased to bring back comments to our articles! Due to threatened de-monetization by Big Tech, we had temporarily removed comments, but we have now implemented a solution to bring back the conversation that Big Tech doesn't want you to have. If you have any problems using the new commenting platform, please contact customer support at commenting-help@insticator.com. Welcome back!